Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1

Author(s):  Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy

Issue:  Jul/Aug 2021 - Volume 25, Number 4
View All Articles in Issue

Abstract:  Container closure integrity provides assurance that compounded sterile preparation quality attributes are met throughout its shelf life. Since compounded sterile preparations lacking container-closure integrity are considered adulterated as per the Federal Food, Drug and Cosmetic Act and are therefore unsafe for patient use, compounders must be able to produce a well-closed sealed vial. Furthermore, 503B outsourcing facilities must qualify the capping process as described by the proposed “Current Good Manufacturing Practice – Guidance for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug and Cosmetic Act Guidance for Industry.” This article is the first in a series describing vial crimping and capping equipment selection and the qualification necessary to create a well-closed sealed vial in a Current Good Manufacturing Practice environment to ensure patient safety and maintain compliance.

Related Keywords: Doral (Neal) O. Higgins, Melanie J. Prudom, MBA, Amy Summers, PharmD, BCSCP, container closure integrity, container-closure system, United States Pharmacopeia Chapter <1207>, package integrity evaluation, compounded sterile preparations, vial crimping, vial capping, vial sealing, vial closing, current good manufacturing practice, US Food and Drug Administration, FDA, capper, crimper, external contamination, 503B pharmacies, component supplier quality certification

Related Categories: LEGAL, PACKAGING, STERILE PREPARATIONS, QUALITY CONTROL

Printer-Friendly Version




Download in electronic PDF format for $45

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1 Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy Jul/Aug 2021 298-302 Buy
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2 Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy Sep/Oct 2021 389-395 Buy
How to Qualify Container Closure Systems for Intended Use, Part 1 Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page Nov/Dec 2019 454-461 Buy
Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues Allen Loyd V Jr Jul/Aug 2021 311-317 Buy
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice Kelley Brian Mar/Apr 2021 115-124 Buy
Choosing a Vial Processing Line for Aseptic Compounding: Part 1 Noorian Shaun, Vahedi Navid Jul/Aug 2016 283-292 Buy
Evaluation of the Efficacy and Superiority of Different Vial Rubber Closure Disinfection Techniques Bjornstad Matthew, Kosinski Tracy, Burlage Robert Sep/Oct 2020 434-438 Buy
How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems Vaughn Stacey R, Radwick Allison Jan/Feb 2020 14-19 Buy
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1 Allen Loyd V Jr Mar/Apr 2020 92 Buy
Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems Akers Michael J Nov/Dec 2015 491-500 Buy